Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

Relation Between Serum Lactate Dehydrogenase and Immune Thrombocytopenia

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07046013

Enrollment

Registered

2025-07-01

Start date

2025-08-31

Completion date

2027-07-31

Last updated

2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Thrombocytopenia (ITP)

Brief summary

Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia

Detailed description

Immune thrombocytopenia is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Lactate dehydrogenase is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate. The LDH was found to be moderately high in patients with immune thrombocytopenia at the time of diagnosis.

Interventions

DIAGNOSTIC_TESTLactate dehydrogenase

It's elevation at the time of diagnosis

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Thrombocytopenia patients at the time of diagnosis.

Exclusion criteria

* bone fractures \_ bone diseases\_ malignancy

Design outcomes

Primary

Measure	Time frame
Relation between serum lactate dehydrogenase and immune thrombocytopenia	About 2 years

Contacts

Primary ContactShaimaa Mahmoud Fahmy, Resident doctor

shaimaa333mahmoud333@gmail.com01149586292

Backup ContactHassnaa Ahmed Abo elwafa, Prof.Dr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026